Abstract
The present study was undertaken to determine the role of adenosine in mediating the cellular responses to hypoxia in rat phaeochromocytoma (PC12) cells, an oxygen-sensitive clonal cell line.
Reverse transcriptase polymerase chain reaction studies revealed that PC12 cells express adenosine deaminase (the first catalysing enzyme of adenosine degradation) and the A2A and A2B adenosine receptors, but not the A1 or A3 adenosine receptors.
Whole-cell current- and voltage-clamp experiments showed that adenosine attenuated the hypoxia-induced membrane depolarization. The hypoxia-induced suppression of the voltage-sensitive potassium current (IK(V)) was markedly reduced by adenosine. Furthermore, extracellularly applied adenosine increased the peak amplitudes of IK(V) in a concentration-dependent manner. This increase was blocked by pretreatment not only with a non-specific adenosine receptor antagonist, 8-phenyltheophylline (8-PT), but also with a selective A2A receptor antagonist, ZM241385.
Ca2+ imaging studies using fura-2 acetoxymethyl ester (fura-2 AM) revealed that the increase in intracellular free Ca2+ during hypoxic exposure was attenuated significantly by adenosine. Voltage-clamp studies showed that adenosine inhibited the voltage-dependent Ca2+ currents (ICa) in a concentration-dependent fashion. This inhibition was also abolished by both 8-PT and ZM241385.
The modulation of both IK(V) and ICa by adenosine was prevented by intracellular application of an inhibitor of protein kinase A (PKA), PKA inhibitor fragment (6–22) amide. In addition, the effect of adenosine on either IK(V) or ICa was absent in PKA-deficient PC12 cells.
These results indicate that the modulatory effects of adenosine on the hypoxia-induced membrane responses of PC12 cells are likely to be mediated via activation of the A2A receptor, and that the PKA pathway is required for these modulatory actions. We propose that this modulation serves to regulate membrane excitability in PC12 cells and possibly other oxygen-sensitive cells during hypoxia.
Although the mechanism of hypoxic chemotransduction is still a matter for discussion, a generally accepted concept is that closure of oxygen-sensitive K+ channels could be an initial trigger for the hypoxia-induced cellular responses (Gonzalez, Almaraz, Obesco & Rigual, 1994; Lopez-Barneo, 1996). Our laboratory has previously shown that rat phaeochromocytoma (PC12) cells, the neoplastic counter-part of adrenal chromaffin cells (Greene & Tischler, 1976), depolarize during hypoxia by inhibition of an O2-sensitive potassium (K+) channel (Zhu, Conforti, Czyzyk-Krzeska & Millhorn, 1996). The membrane depolarization in PC12 cells during hypoxia leads to activation of voltage-dependent calcium (Ca2+) channels, Ca2+ entry and an increase in cytosolic Ca2+, which are essential for regulation of a number of O2-responsive genes and the release of neurotransmitters (Raymond & Millhorn, 1997; Zhu, Conforti & Millhorn, 1997). These responses to hypoxia in PC12 cells are essentially similar to those reported in the type I cells of the mammalian carotid body, which is a major oxygen-sensing organ that is responsible for mediating the hyperventilatory response during hypoxia (Buckler & Vaughan-Jones, 1994). Both carotid body type I cells and PC12 cells originate from neural crest and both synthesize dopamine as their major neurotransmitter.
Adenosine is an endogenous metabolite of ATP which is produced and released in various tissues in response to a number of physiological and pathological conditions, including hypoxia (Winn, Rubio & Berne, 1981). In recent years it has been shown that adenosine mediates a number of different cellular activities via specific receptors (Dalziel & Westfall, 1994; Fredholm, 1995). The four cloned adenosine receptors are classified as A1, A2A, A2B and A3 (Palmer & Stiles, 1994; Olah & Stiles, 1995). The A1 and A3 receptors are generally coupled to Gi protein and mediate inhibition of adenylate cyclase activity. The A2 receptor family, A2A and A2B receptors, are almost always coupled to Gs protein, which stimulates adenylate cyclase activity. The A1 and A2 receptors appear to have distinct roles in protecting against the inadequate tissue oxygenation during hypoxia (Bruns, 1990). A1 responses generally bring about a decrease in the amount of metabolic activity, while A2 responses usually increase oxygen delivery by enhancing blood flow. Therefore, adenosine could be involved in the regulation of the cellular response to hypoxia. However, the mechanisms by which this occurs remain unknown.
The present study was undertaken to determine if adenosine modulates the basic ionic response to hypoxia in PC12 cells. We confirm earlier reports that PC12 cells express the A2A and A2B receptor subtypes but not the A1 or A3 subtypes (Hide, Padgett, Jacobson & Daly, 1992; van der Ploeg, Ahlberg, Parkinson, Olsson & Fredholm, 1996). Importantly, we found that extracellularly applied adenosine modulates the effect of hypoxia on membrane depolarization by increasing the voltage-sensitive K+ current and reducing the voltage-dependent Ca2+ current, which leads to decreased membrane depolarization and decreased intracellular free Ca2+ during hypoxia in PC12 cells. These modulatory actions of adenosine were blocked by a selective A2A receptor antagonist, ZM241385, and by the protein kinase A inhibitor (PKI). Modulatory actions of adenosine were absent in a PKA mutant PC12 cell line. To our knowledge, this is the first report which describes the role of adenosine in modulating the cellular response during hypoxia in an O2-sensitive cell. We propose that adenosine, via the A2A receptor, plays a critical role in regulating membrane excitability and cytosolic Ca2+ levels in PC12 cells and other O2-sensitive cells during hypoxia.
METHODS
Cell culture
PC12 cells were obtained from American Tissue Culture Collection (Rockville, MD, USA), and grown in Dulbecco's modified Eagle's medium-Ham's F-12 (DMEM-F-12; Gibco) containing 15 mm Hepes buffer, 2 mm L-glutamine, 10 % fetal bovine serum and penicillin-streptomycin (100 u ml−1 and 100 μg ml−1, respectively) in an incubator in which the environment (21 % O2 and 5 % CO2 (remainder N2); 37°C) was strictly maintained. The medium was changed twice a week. PKA-deficient cells (A123.7; Ginty, Glowacka, DeFranco & Wagner, 1991) were grown in Dulbecco's modified Eagle's medium with high glucose (DMEM-H) containing 15 mm Hepes, 10 % fetal bovine serum, 5 % horse serum and 100 μg ml−1 gentamicin, in an environment of 21 % O2 and 10 % CO2, at 37°C.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Cytoplasmic RNA was isolated from PC12 cells using TRI-REAGENT (Molecular Research Center, Cincinnati, OH, USA). RT-PCR was performed using the GeneAmpli kit (Perkin-Elmer, Norwalk, CT, USA) according to the manufacturer's instructions. Briefly, for the reverse transcriptase reaction, 1 μg of purified total RNA was incubated in the presence of: 2.5 μm oligo(dT) primer (16mer); 1 mm deoxynucleotide triphosphates; 1 U RNase inhibitor; and 2.5 U murine leukaemia virus (MuLV) reverse transcriptase, denatured at 85°C for 5 min, and incubated at 42°C for 15 min to allow the reaction to proceed. The reaction was terminated by heating to 95°C for 5 min and then the sample was maintained at 5°C for 5 min. The primers for rat A1, A2A, A2B and A3 adenosine receptors, and for mouse adenosine deaminase were as follows: A1 receptor, 5′-CGGCAGCACCCAGACGAAGA-3′ and 5′-CCCACCATGCCGCCCTACAT-3′ (the predicted length of the amplified DNA fragment should be 579 bp); A2A receptor, 5′-TTCAAAGTGGGAGCCACGCA-3′ and 5′-ATGGGC TCCTCGGTGTACATC-3′ (predicted fragment length, 1320 bp); A2B receptor, 5′-GCCTCGAGTGCTTTACAGACCCCC-3′ and 5′-GAAAGTTGACTGTCCCCCGGCCTG-3′ (predicted frag-ment length, 885 bp); A3 receptor, 5′-CACATCCTGCTGAAG AAGCAACAG-3′ and 5′-GAGCTGGCTCTTTATCTGTCA TGG-3′ (predicted fragment length, 1045 bp); adenosine deaminase, 5′-AAGGTCCGGTCCATTCTGTG-3′ and 5′-AGG GGGTCGTCTGTGTTGAG-3′ (predicted fragment length, 455 bp).
DNA amplification was accomplished in the presence of 1.5 mm MgCl2, 1 × reaction buffer and 2.5 U AmpliTaq DNA polymerase. The PCR conditions were as follows. Denaturation for 2 min at 94°C, followed by thirty-five cycles consisting of: 90 s at 94°C; 1 min at 50°C (for the A1 and A2A receptors), or 60°C (for the A2B and A3 receptors), or 52°C (for adenosine deaminase); and 2 min at 72°C (for the A2A receptor), or 90 s at 72°C (for the A1 receptor, A2B receptor, A3 receptor and adenosine deaminase). The samples were then kept at 72°C for 7 min. The products of RT-PCR were analysed by electrophoresis on 1 % agarose gels and identity was verified by sequence analysis.
Patch-clamp recordings
The methods for patch-clamp recordings were essentially the same as those described previously (Zhu et al. 1996). The cells were plated on coverslips and placed in a perfusion chamber (volume, 200–400 μl) mounted on the stage of an inverted interference microscope (ITM-2, Olympus, Japan) and constantly perfused with the recording solution at a flow rate of 2–3 ml min−1. Voltage-dependent potassium current (IK(V)) and calcium current (ICa) were recorded in the conventional whole-cell voltage-clamp mode (Hamill, Marty, Neher, Sakmann & Sigworth, 1981) by using an Axopatch-200A amplifier (Axon Instruments). The patch pipettes had resistances of 4–5 MΩ when filled with an internal solution, except when otherwise mentioned All the experiments were performed at room temperature (25°C).
The IK(V) were recorded using patch pipettes filled with (mm): 140 potassium gluconate, 1 CaCl2, 11 EGTA, 2 MgCl2, 3 Na-ATP, 10 Hepes and 0.2 GTP (pH adjusted to 7.2 with KOH). The composition of the external solution was (mm): 140 NaCl, 2.8 KCl, 2 CaCl2, 2 MgCl2, 10 Hepes and 10 glucose (pH adjusted to 7.4 with NaOH). The term IK(V) refers to the total voltage-sensitive K+ current evoked by a voltage step in our experimental protocol. A previous paper from our laboratory has shown that this current (IK(V)) contains the O2-sensitive component termed IK(O2) (Zhu et al. 1996). For the measurement of ICa, Ba2+ was used as the charge carrier. The pipette solution for ICa included (mm): 140 caesium gluconate, 1 CaCl2, 2 MgCl2, 10 EGTA, 10 Hepes, 3 Na-ATP and 0.2 GTP (pH adjusted to 7.2 with Tris-base), while the external solution included (mm): 122 N-methylglucamine-glutamate, 20 BaCl2, 2 MgCl2, 2.8 CsCl, 10 Hepes, 10 glucose (pH adjusted to 7.4 with Tris-base).
Spherical PC12 cells of 10–15 μm in diameter were voltage clamped using the tight-seal whole-cell recording method. Seventy to seventy-five per cent of the series resistance (< 9 MΩ) was compensated electronically. All solutions containing drugs were applied extracellularly after stable recordings of IK(V) or ICa had been obtained (usually 3 min after establishing the whole-cell configuration). Current signals were electronically filtered at 1 kHz and digitally sampled. The digitized signals were analysed on a personal computer using pCLAMP 5.5 (for current signals) and Axotape (for voltage signals) analysis programs (Axon Instruments).
In the present study, hypoxia was obtained by equilibrating the perfusion medium with 10 % O2 gas (balanced with N2), which resulted in a PO2 in the media of approximately 80 mmHg. In some cases the media was buffered with 100 % N2 in the presence of 1 mm sodium dithionate (Na2S2O4), an O2 chelator. This procedure caused the PO2 of the media to fall below 10 mmHg.
Ca2+ imaging
The cytosolic free Ca2+ concentration ([Ca2+]i) was evaluated using the fluorescent Ca2+ indicator fura-2 acetoxymethyl ester (fura-2 AM; Molecular Probes). PC12 cells were incubated with fresh serum-free DMEM-F12 medium containing fura-2 AM (5 μm) and Pluronic F127 (0.01 %) for 40 min at 37°C. The cells were then rinsed twice with the same medium without fura-2 AM and left at 37°C for 30 min to allow for hydrolysis of the ester. The coverslips containing the cells were then placed in a Sykes-Moore chamber. Fluorescence imaging was conducted using a xenon fluorescent light source at alternating excitation wavelengths of 340 and 380 nm. Images were captured with a Hamamatsu SIT camera mounted to a Zeiss IM35 fluorescence microscope with a × 40 quartz objective. The integrated light intensities of the cells were measured at 340 and 380 nm by Image-I software (Universal Imaging Corp.) after background subtraction. The ratio of F340/F380 was used as an indicator of [Ca2+]i, because this allows measurement of [Ca2+]i independent of intracellular fura-2 AM concentration. Experimental solutions were perfused by a peristaltic pump at a flow rate of 5 ml min−1.
Data analysis
The results are expressed as means ±s.e.m. (n, number of observations). An analysis of variance (ANOVA) was used for determining the significance of the measured variables. Statistical significance was accepted at the P < 0.05 level.
Materials
Adenosine, 8-phenyltheophylline, protein kinase A inhibitor fragment (6–22) amide and sodium dithionate were obtained from Sigma. ZM241385 was purchased from Tocris Cookson (Ballwin, MO, USA).
RESULTS
PC12 cells express A2A and A2B receptors but not A1 or A3 receptors
RT-PCR studies were performed to determine the expression of adenosine receptors in PC12 cells (Fig. 1). Upstream and downstream primers for rat A1, A2A, A2B and A3 receptors were constructed and used, based on the known rat cDNA sequence. Results from these experiments revealed that both the A2A and A2B receptors, but not the A1 or A3 receptors, are expressed in PC12 cells (Fig. 1A). Expression of the A1 and A3 receptors was detected as a single band in positive control samples (rat brain and rat lung, respectively; Fig. 1A). Analyses of the sequenced PCR products revealed 100 % homology with the GenBank cDNA sequences for both the A2A and A2B receptors. These findings confirm that rat PC12 cells selectively express the A2A and A2B receptor mRNAs. Although it could be argued that the presence of mRNAs does not always reflect the presence of protein, it is highly unlikely that the mRNAs exist but the protein is not expressed.
Figure 1. Expression of adenosine receptor and adenosine deaminase mRNA in PC12 cells detected by RT-PCR.

A, ethidium bromide visualization of PCR products obtained by RT-PCR of total RNA from PC12 cells for adenosine A1, A2A, A2B and A3 receptors. Pairs of oligonucleotides were used as primers to specifically amplify the cDNA fragments of these receptors as described in Methods. The PCR products were analysed by 1 % agarose gel electrophoresis in the presence of ethidium bromide. The left-hand lane corresponds to PCR (Promega) or pGEM markers (Promega) - the sizes of the DNA fragments for each marker are indicated on the left. RT-PCR revealed that PC12 cells express both A2A and A2B adenosine receptors (predicted product size, 1320 and 885 bp, respectively). On the other hand, neither the A1 nor the A3 adenosine receptors were detected in PC12 cells (predicted size, 579 and 1045 bp, respectively). Total RNAs from rat whole brain and rat lung were used as positive controls for A1 and A3 receptors. False amplification of the genomic DNA was ruled out by performing RT-PCR without reverse transcriptase, as a negative control (shown as RT-). B, RT-PCR for adenosine deaminase. PC12 cells express adenosine deaminase (predicted size, 455 bp).
We also performed RT-PCR to determine whether PC12 cells express adenosine deaminase, the enzyme that catalyses the first step in adenosine degradation. The primer pairs were constructed based on the known mouse cDNA sequence. RT-PCR revealed that PC12 cells do indeed express the mRNA for this enzyme (Fig. 1B), which is evidence that adenosine is present in PC12 cells.
Effect of adenosine on the hypoxia-induced membrane depolarization
Our laboratory has previously shown that hypoxia induces membrane depolarization by suppressing an oxygen-sensitive K+ current in PC12 cells (Zhu et al. 1996; Conforti et al. 1997). We first examined the effect of extracellularly applied adenosine on the hypoxia-induced membrane depolarization. Figure 2A shows the effect of hypoxia (10 %) on membrane potential (Vm) before and after application of adenosine (10 μm). Hypoxia caused depolarization of the membrane potential, which returned to the baseline level after reoxygenation. The hypoxia-induced depolarization was markedly reduced in the presence of adenosine. Following recovery, a subsequent hypoxic exposure without adenosine once again led to depolarization to the same magnitude as that measured prior to adenosine treatment. Figure 2B summarizes the effect of hypoxia and adenosine on membrane potential. The results were obtained following single applications of hypoxia alone, hypoxia with adenosine, or adenosine alone on different cells. Each group represents the mean result from five separate cells. There were no significant differences in the resting membrane potential among the three groups (hypoxia, -33.7 ± 4.2 mV; hypoxia with adenosine, -31.6 ± 2.9 mV; adenosine, -29.6 ± 3.6 mV). Single application of adenosine (10 μm) itself led to membrane hyperpolarization. Taken together, the results show that the hypoxia-induced depolarization in PC12 cells is counteracted by adenosine.
Figure 2. Effect of adenosine on hypoxia-induced membrane depolarization in PC12 cells.

A, time course of the effect of hypoxia on membrane potential (Vm) with and without application of adenosine (ADO; 10 μm), measured by using the current-clamp technique. Hypoxia elicited membrane depolarization, and the Vm returned to the baseline level after reoxygenation. Hypoxia was induced by 10 % O2. When the cell was then exposed to hypoxia in the presence of adenosine (10 μm), it showed slight, reversible hyperpolarization. A subsequent hypoxic exposure without adenosine revealed depolarization to the same extent as the first hypoxic trial. Shaded areas show the period of hypoxic exposure (
) and hypoxia with adenosine (10 μm;
). B, the mean data for the effect of hypoxia and/or adenosine on Vm. The results were obtained by single applications of hypoxia alone (n= 5;
), hypoxia with adenosine (10 μm, n= 5;
) or adenosine alone (10 μm, n= 5; ▪) on different cells. Hypoxia induced membrane depolarization, while it induced hyperpolarization in the presence of adenosine (10 μm). Single applications of adenosine (10 μm) led to hyperpolarization.
Activation of A2 receptors enhances voltage-sensitive K+ current and reduces the hypoxia-induced inhibition of IK(V) in PC12 cells
We performed additional experiments to characterize the modulation of the outward K+ current by adenosine in PC12 cells. Figure 3A shows the representative time course of the effects of adenosine on IK(V) under normoxia. We found that exogenously applied adenosine (10 μm) enhanced the outward IK(V). The maximal response was observed at 2.5 ± 0.5 min (n= 14) following the application of adenosine, and the increased level of the outward current persisted for almost 1 min following washout of adenosine. The current then declined gradually, and returned to the initial baseline level within 4.2 ± 0.67 min (n= 8). Figure 3B shows a representative trace for the effect of adenosine on the current-voltage relationship of IK(V). Depolarizing ramps from −60 to +50 mV of 500 ms duration were used. The resulting currents were measured during control and after 3 min exposure to adenosine (10 μm). We measured an increased outward current and shifted reversal potential (Vrev) in the presence of adenosine. The baseline Vrev was −35.3 ± 4.2 mV (n= 5), and shifted to −46.9 ± 4.0 mV (n= 5, P < 0.05) following the application of adenosine. Since the ramps were not leak subtracted, the shift in reversal potential reflects the increased contribution of IK(V) to total cell current. Figure 3C shows the concentration-dependent effect of adenosine on IK(V). Adenosine (10 μm) increased the amplitude of IK(V) by 49.6 ± 5.6 % (n= 14). A maximal increase (126 ± 16 % above baseline level) was measured with 50 μm adenosine. This effect of adenosine appears to be mediated via a receptor mechanism since the effect of adenosine on IK(V) was blocked by a non-specific adenosine receptor antagonist, 8-phenyltheophylline (8-PT; data not shown). At a concentration of 10 μm, 8-PT markedly reduced the effect of adenosine (10 μm) on IK(V) (5.2 ± 2.5 % change from baseline, n= 5). 8-PT itself did not induce any change in IK(V) (0.1 ± 1.2 %, n= 5). 8-PT is known to act primarily as an adenosine receptor blocker, and the phosphodiesterase inhibitor activity of this drug is very small at the concentration used in this study (Smellie, Davis, Daly & Wells, 1979). We further found that the facilitating effect of adenosine was blocked by the selective A2A receptor antagonist, ZM241385 (Table 1).
Figure 3. Effect of adenosine on voltage-dependent K+ current in PC12 cells.

A, time course of the effect of adenosine on IK(V). IK(V) was measured every 15 s with depolarizing steps to +50 mV from a Vh of −80 mV (800 ms duration). The current amplitude was measured at the end of the test pulse. Adenosine (ADO; 10 μm) induced a reversible enhancement in the amplitude of IK(V). Shaded area (
) corresponds to the time of adenosine application. Inset, superimposed current traces recorded in the absence (a and c) and presence (b) of adenosine. B, effect of adenosine on the current-voltage relationship of IK(V). A representative trace is shown. The study was done by ramp-depolarizing voltage pulses from -60 to +50 mV with 500 ms duration. Currents generated by ramp pulse were measured before and after the application of adenosine (10 μm). Each trace shows the mean of the currents generated by 5 repeated ramp pulses. Adenosine caused an increased outward current and also induced a shift in the reversal potential towards more negative potentials. C, concentration-dependent enhancement of IK(V) by adenosine. The vertical line refers to the percentage increase from baseline in the amplitude of IK(V), which is evaluated at the end of depolarizaing step pulses, similar to A. Adenosine enhanced IK(V) in a concentration-dependent manner. A maximal increase was measured with 50 μm adenosine. In these experiments, all the measurements were done separately, in different cells. The numbers in the parentheses are the number of cells tested.
Table 1.
Effect of adenosine A2A receptor antagonist ZM241385 on the response of IK(V) and ICa to adenosine
| Percentage change from baseline | ||
|---|---|---|
| IKV | ICa | |
| 50 μm adenosine | 112.4 ± 12.5 (4) | −48.9 ± 3.5 (5) |
| 10 nm ZM241385 | −1.6 ± 0.8 (4) | 2.2 ± 0.7 (4) |
| 10 nm ZM241385 + | ||
| 50 μm adenosine | 5.0 ± 0.3 (4) * | −4.9 ± 1.2 (4) * |
Values are means ±s.e.m. The numbers of cells tested are shown in parentheses.
Significant difference (P < 0.01) from the value in the presence of 50 μm adenosine.
We next examined the effect of A2 receptor activation on the hypoxia-induced change of IK(V) in PC12 cells. Depolarizing step pulses from a holding potential (Vh) of −80 mV to +50 mV (800 ms in duration) were used to evoke IK(V). Current amplitudes were measured at the end of the test pulse. Figure 4A shows the effect of adenosine (10 μm) on IK(V) during hypoxia. Hypoxia was obtained by exposing cells to 10 % O2, which led to a 20 % reduction in IK(V). Adenosine counteracted this effect by increasing IK(V) to a level that was slightly higher than the original baseline level. Figure 4B shows the mean results from this series of experiments. The enhancement of IK(V) by adenosine during hypoxia could account for the hyperpolarization that was reported in the previous section.
Figure 4. Effect of adenosine on hypoxia-induced IK(V) inhibition in PC12 cells.

A, time course of the change in IK(V) during hypoxia before and during application of adenosine (ADO; 10 μm). IK(V) was measured every 15 s with depolarizing steps to +50 mV from a Vh of −80 mV (800 ms duration). Current amplitude was measured at the end of the test pulse. Hypoxia was obtained with 10 % O2 in this experiment. Hypoxia-induced inhibition of the IK(V) was counteracted by subsequent administration of adenosine. Shaded areas correspond to the period of hypoxic exposure (
) and the application of adenosine (
). Inset, IK(V) currents corresponding to control period (a), exposure to hypoxia (b) and after application of adenosine (c). B, mean data for this experiment (±s.e.m., n= 8). The response was evaluated as percentage change from baseline outward current. Columns show hypoxia (
) and hypoxia in the presence of adenosine (10 μm;
).
Effect of adenosine on intracellular free Ca2+ during hypoxia
Our laboratory reported previously that hypoxia increases intracellular free Ca2+ levels ([Ca2+]i) in PC12 cells (Zhu et al. 1996). In the current study, we performed experiments to determine if adenosine modulates the hypoxia-induced enhancement of [Ca2+]i in PC12 cells. Figure 5A shows a representative recording of [Ca2+]i in the absence and presence of adenosine (50 μm). Hypoxia (100 % N2 and 1 mm sodium dithionate) produced a gradual rise in [Ca2+]i which reached a peak within 5 min and returned to the baseline levels following reoxygenation. The peak levels of [Ca2+]i were similar during the first and second exposures to hypoxia. The hypoxia-induced enhancement of [Ca2+]i was reduced in the presence of adenosine (50 μm). Upon removal of adenosine from the perfusate, an increase in [Ca2+]i was elicited when the cells were re-exposed to hypoxia alone. Figure 5B summarizes the results from the Ca2+-imaging studies. These results show clearly that adenosine inhibits the hypoxia-induced enhancement of [Ca2+]i in PC12 cells.
Figure 5. Effect of adenosine on hypoxia-induced enhancement of intracellular free Ca2+ in PC12 cells.

A, representative measurement of cytosolic free Ca2+ concentration ([Ca2+]i) during hypoxia in the presence and absence of adenosine. [Ca2+]i was estimated by using the fluorescent Ca2+ indicator fura-2 AM. Imaging was conducted using a xenon fluorescent light source at alternating excitation wavelengths of 340 and 380 nm. The ratio of F340/F380 was used to reflect [Ca2+]i. Solutions were perfused by a peristaltic pump at a flow rate of 5 ml min−1. Hypoxia was induced by saturating the 1 mm sodium dithionate-containing perfusate with 100 % N2. Hypoxia induced the elevation of [Ca2+]i, which returned to the baseline level upon reoxygenation. The response to hypoxia was similar for two repeated exposures. The response was reduced in the presence of adenosine (ADO; 50 μm). The final increase in [Ca2+]i is due to depolarization induced by high K+ (30 mm). Shaded areas correspond to the period of hypoxic exposure (
) and hypoxia with adenosine (
). B, averaged data from Ca2+ imaging study. The cells were first exposed to hypoxic perfusate, and then to hypoxia alone again or to hypoxia with 50 μm adenosine. These two protocols were conducted in separate groups of cells (n= 12 and 14, respectively). There were no differences in the peak levels of [Ca2+]i between the first and second hypoxic exposure (left). On the other hand, the enhancement of [Ca2+]i during hypoxia was significantly inhibited in the presence of adenosine (right).
Activation of A2 receptors inhibits a voltage-dependent Ca2+ current in PC12 cells
To further investigate the mechanisms by which adenosine attenuated the hypoxia-induced enhancement of intracellular Ca2+, the direct effects of adenosine on voltage-dependent Ca2+ currents were studied in PC12 cells. Figure 6A shows the peak current-voltage relationship before and after the application of adenosine (10 μm). ICa was measured with test pulses of 100 ms duration from a Vh of −80 mV to test potentials from −50 to +60 mV. Adenosine (10 μm) reduced the amplitude of ICa by 39.3 ± 7.8 % at +20 mV (n= 6). The effect of adenosine on ICa was determined as a percentage change by comparing the peak amplitude of ICa in the presence of adenosine to that of ICa prior to the exposure to adenosine. The time course of adenosine-induced inhibition of ICa is shown in Fig. 6B. Ca2+ current was elicited from a Vh of −80 mV with depolarizing steps to +20 mV (pulses of 160 ms duration). The effect of adenosine on ICa reached a peak in 1.0 ± 0.3 min (n= 6) and recovered to the original control level within 2.5 ± 0.5 min after the start of washout. We found that adenosine inhibited ICa in a concentration-dependent manner (Fig. 6C). The inhibitory effect of adenosine (10 μm) on ICa was blocked by an adenosine receptor antagonist, 8-PT (10 μm; −5.7 ± 4.4 % change from baseline, n= 5). 8-PT itself did not induce any change in ICa (−1.4 ± 5.1 %, n= 5; data not shown). In addition, the effect of adenosine on ICa was also blocked by a selective A2A receptor antagonist, ZM241385 (Table 1).
Figure 6. Effect of adenosine on voltage-dependent Ca2+ current in PC12 cells.

A, peak current-voltage relationship before and after the application of adenosine (ADO; 10 μm). ICa was measured with 100 ms-long test pulses from a Vh of −80 mV to test potentials ranging from −50 to +60 mV (10 mV increments). Adenosine decreased ICa at the voltage range examined. B, time course of the effect of adenosine on ICa. ICa was measured at room temperature every 30 s by 160 ms test pulses from a Vh of −80 to +20 mV. Peak current amplitude was measured for evaluation. The charge carrier was 20 mm Ba2+. Adenosine (10 μm) elicited a decrease in the amplitude of ICa, which fully returned to baseline level after washing. Inset, superimposed current traces recorded before (a), during (b) and after (c) application of adenosine. C, concentration-response relationship of the effect of adenosine on ICa. Adenosine reduced the peak ICa in a concentration-dependent manner. The response was evaluated as percentage decrease from baseline inward currents. The numbers in parentheses indicate the number of cells for each data point.
Protein kinase A (PKA) mediates IK(V) and ICa responses to adenosine
Activation of the A2 receptor is thought to be associated with stimulation of adenylate cyclase and activation of PKA (Dalziel et al. 1994; Fredholm, 1995). We hypothesized, therefore, that the effects of adenosine on IKV and ICa are mediated by PKA. To test this possibility, we examined the effect on IKV and ICa in cells in which PKA was blocked by the PKA inhibitor fragment (6–22) amide (PKI). This small, heat-stable inhibitory peptide binds to the catalytic subunit of PKA and inactivates the enzyme (Glass, Lundquist, Katz & Walsh, 1989). Dialysis of cells with a pipette solution containing PKI has been shown to effectively inhibit the PKA-mediated current events (Schackow & Ten Eick, 1994). In the present study, PC12 cells were dialysed with PKI (100 μm) using large-tip pipettes of 1–2 MΩ resistance for at least 6 min prior to the start of an experiment. We found that the intracellularly applied PKI abolished the effect of adenosine on IK(V) and ICa (Fig. 7A).
Figure 7. Involvement of protein kinase A in the response of IK(V) and ICa to adenosine.

A, abolition of the effects of adenosine on IK(V) and ICa by intracellular PKA inhibitor fragment (6–22) amide (PKI). PC12 cells were dialysed with a pipette solution including 100 μm PKI using large-opening pipettes of 1–2 MΩ resistance for at least 6 min. The experiments were started after steady-state levels of IK(V) or ICa currents were achieved. Voltage protocols were the same as those described in the legends of Figs 3 and 6. Stimulatory effect of adenosine (ADO; 10 μm) on IK(V) (left;
) was significantly abolished in the presence of PKI in a pipette solution (left; ▪). Similarly, inhibitory action of adenosine (10 μm) on ICa (right;
) was significantly reduced by PKI (right; ▪). B, absence of the effects of adenosine on IK(V) and ICa in PKA-deficient PC12 cells (A123.7), which lack PKA activity by genetic mutation. In PKA-deficient PC12 cells, the effect of adenosine (10 μm) on IK(V) and ICa was not observed (▪), while wild-type PC12 cells cultured under the same conditions as A123.7 cells showed the usual response (
). The numbers in the parentheses are the number of cells tested.
These results were confirmed by our finding that adenosine failed to induce significant changes in either IK(V) or ICa in mutant PC12 cells which are deficient in PKA (A123.7; Ginty et al. 1991). The results from these experiments are shown in Fig. 7B. To rule out the possibility that these results were due to the absence of adenosine receptors in A123.7 cells, we examined the expression of adenosine receptors in these cells by RT-PCR. We found that the A123.7 cells express both the A2A and A2B receptors at approximately the same level as wild-type PC12 cells (Fig. 8). Taken together, these results show that the effects of adenosine on IKV and ICa are mediated via the PKA pathway.
Figure 8. Expression of adenosine receptors in PKA-deficient PC12 cells.

Ethidium bromide visualization of PCR products obtained by RT-PCR of total RNA for adenosine receptors in PKA-deficient PC12 cells. Size markers, pGEM and PCR marker, are shown in the left-hand lanes (the sizes of the DNA fragments are indicated on the left). Pairs of oligonucleotides were used for RT-PCR as described in Methods. RT-PCR was performed according to the same protocols as those shown in Fig. 1. This cell line expresses both A2A and A2B receptors. Neither A1 nor A3 receptors were detected in PKA-deficient cells. The results were the same as the wild-type PC12 cells shown in Fig. 1. Negative controls without reverse transcriptase (labelled as RT-) were performed for each gene in order to assess any genomic DNA contamination.
DISCUSSION
The present study was undertaken to investigate the role of adenosine in modulating the cellular responses to hypoxia in PC12 cells. We confirmed that these cells express both the A2A and A2B receptors, but not the A1 or A3 receptors. An important observation was that membrane depolarization and enhancement of intracellular free Ca2+ during hypoxia are markedly attenuated by adenosine in PC12 cells. We also found that the voltage-sensitive K+ current (IK(V)) and hypoxia-induced suppression of the IK(V) are greatly attenuated by adenosine. Moreover, our results show that activation of the A2 receptor inhibited the voltage-activated Ca2+ current. Our data revealed that the effects of adenosine on these currents are mediated via A2A receptors and that PKA is necessary for adenosine action. These results provide strong evidence that adenosine modulates membrane excitability during hypoxia in PC12 cells, and that these effects are mediated by the action of adenosine on both K+ and Ca2+ currents through the A2A receptor and a PKA-dependent intracellular signalling pathway.
We examined the expression of adenosine receptor subtypes in PC12 cells. Adenosine receptors were identified in PC12 cells in an early study using a ligand-binding technique (Williams, Abreu, Jarvis & Noronha-Blob, 1987). More recent studies using ligand binding (Hide et al. 1992) and RT-PCR (van der Ploeg et al. 1996) revealed that PC12 cells express both A2A and A2B receptors. However, the presence of A1 or A3 receptors was not investigated. Our experiments using RT-PCR confirm these earlier findings, and in addition, we report that neither A1 nor A3 receptor mRNAs are present in these cells.
An important finding in the current study was that membrane depolarization and the increase in intracellular free Ca2+ evoked by hypoxia were significantly attenuated by adenosine in PC12 cells. This is important because adenosine is one of the major mediators for many physiological and pathophysiological responses that are associated with hypoxia in different tissues (Bruns, 1990; Dalziel & Westfall, 1994; Fredholm, 1995). Since the effects of adenosine on IK(V) and ICa were blocked by the selective A2A receptor antagonist ZM241385, it is likely that these effects of adenosine on the hypoxia-induced cellular responses are mediated via A2A receptors. ZM241385 is selective for A2A receptors and blocks only this A2 subtype at the concentration used in this study (Poucher et al. 1994). It has been shown that the A2A and A2B receptors have different tissue distributions and ligand affinities (Olah et al. 1995). Both receptors are thought to be coupled to the Gs protein which stimulates adenylate cyclase activity. However, it takes a 100-fold higher concentration of the specific A2 receptor agonist NECA (5′-N-ethyl-carboxamidoadenosine) to stimulate the A2B receptor than the A2A receptor (Chern, Lai, Fong & Liang, 1993). Since PC12 cells only express the A2 receptors, the possible cross-reactivity with A1 and A3 receptors is not a problem.
Our results suggest that the enhancement of the voltage-sensitive K+ current (IK(V)) by adenosine is the possible mechanism for the reduced membrane depolarization during hypoxia in PC12 cells. This is because the activation of A2 receptors with adenosine enhances IK(V), and this effect, which leads to membrane hyperpolarization, was abolished by pretreatment of the cells with the adenosine receptor antagonist. Furthermore we showed that the hypoxia-induced inhibition of IK(V) is significantly counteracted by adenosine. Adenosine was previously shown to increase resting K+ conductance via the A1 receptor in CNS neurons, which, in turn, decreased cellular excitability (Gerber, Greene, Haas & Stevens, 1989). However, very little information exists concerning the role of the A2 receptor in modulating K+ currents. It would also be important to establish whether adenosine acts on the hypoxia-sensitive K+ channel (IK(O2)) and other subtypes of the K+ channel. A previous paper from our laboratory has revealed that the IK(O2) in PC12 cells has characteristics similar to those of the delayed rectifier-like IK (Zhu et al. 1996). A recent single-channel experiment has shown the type of K+ channel that is present in PC12 cells (Conforti & Millhorn, 1997). It was revealed that only the 20 pS delayed rectifier K+ channel is inhibited by hypoxia. There have been several reports which indicate that the A2 receptors modulate the ATP-sensitive K+ channel (IK(ATP)), which is believed to be involved in hypoxia-induced coronary artery dilatation (Kleppisch & Nelson, 1995). The modulation of K+ currents in response to adenosine cannot be ascribed to IK(ATP) activation, since the concentration of ATP in our recording pipette was sufficient to inactivate IK(ATP). In the current study, we are not able to distinguish whether adenosine and hypoxia act on the same set of K+ channels. Single-channel experiments will have to be conducted to determine whether adenosine-responsive K+ channels are the same as the IK(O2).
The increase in [Ca2+]i during hypoxia in oxygen-sensitive cells occurs as the result of membrane depolarization and activation of voltage-dependent Ca2+ channels (Gonzalez et al. 1994; Lopez-Barneo, 1996). In the carotid body cells, the hypoxia-induced increase in [Ca2+]i is inhibited by pharmacological blockade of voltage-gated Ca2+ channels (Buckler & Vaughan-Jones, 1994). Ca2+ channel blockers have also been shown to inhibit the hypoxia-induced enhancement of [Ca2+]i in PC12 cells (Raymond & Millhorn, 1997). Therefore it seems most likely that the increase in [Ca2+]i during hypoxia in PC12 cells is mediated by the activation of voltage-gated Ca2+ channels. The mechanism by which adenosine causes the attenuation of hypoxia-evoked enhancement of [Ca2+]i is unknown, but could be due to the effect of adenosine on the voltage-dependent Ca2+ channels. Support for this comes from the finding that extracellularly applied adenosine inhibited the voltage-dependent Ca2+ currents in PC12 cells, and that this effect was blocked by the adenosine receptor antagonist. To our knowledge, this is the first evidence that a voltage-gated ICa is modulated by activation of the A2 receptor in PC12 cells. It was recently reported that adenosine inhibits Ca2+ currents in guinea-pig adrenal chromaffin cells, but the specific receptor that mediates this response was not identified (Otsuguro, Ohta, Ito & Nakazato, 1996). In PC12 cells, adenosine has been shown to modulate the ATP-activated non-selective cation channels, which are related to the ATP-evoked Ca2+ influx (Inoue, Watano, Koizumi, Nakazawa & Burnstock, 1994). Adenosine has been shown to reduce voltage-activated Ca2+ currents via the A1 receptor in neuronal cells (Scholz & Miller, 1991). Our findings indicate that the A2 receptor regulates the ICa and the level of intracellular free Ca2+ in a manner that is similar to that reported for A1 receptor activation in the nervous system (Fredholm & Dunwiddie, 1988).
Our findings reveal that PKA is required for the A2 receptor modulation of both IK(V) and ICa in PC12 cells. This conclusion is based on our results which showed that the effects were blocked by PKI and absent in PKA-deficient PC12 cells. These results are in agreement with the traditional notion that the A2 receptor is associated with stimulation of adenylate cyclase via Gs protein (Dalziel et al. 1994; Fredholm, 1995). Although the regulation of ion channels by G proteins has been intensively investigated (Wickman & Claphan, 1995), relatively little is known about the coupling of the A2 receptor to either the K+ or Ca2+ channel in PC12 cells. Our study suggests that activation of the cAMP-PKA pathway leads to inhibition of Ca2+ channels and stimulation of K+ channels. It is generally known that cAMP stimulates the L-type Ca2+ channel in cardiac muscles and skeletal muscles (Wickman & Claphan, 1995) and modulates the gating properties of L-type Ca2+ channels in bovine adrenal chromaffin cells, which are phenotypically similar to PC12 cells (Doupnik & Pun, 1992). However, it is possible that the action of cAMP on Ca2+ channel activities is tissue dependent, since cAMP acts to inhibit the opening of L-type Ca2+ channels at depolarized potentials in vascular smooth muscle cells (Sperelakis, Xiong, Haddad & Masuda, 1994). The inhibition of ICa and the stimulation of IK(V), induced by the activation of PKA by adenosine, would suppress membrane depolarization elicited by hypoxia and thereby diminish the Ca2+ influx during hypoxia. Our laboratory has shown that intracellular free Ca2+ is required for the regulation of tyrosine hydroxylase gene expression during hypoxia in PC12 cells (Raymond & Millhorn, 1997). We have also shown that dopamine is released from PC12 cells during hypoxia (Zhu et al. 1997). Therefore it is possible that A2 receptor-mediated regulation of the membrane potential and the intracellular free Ca2+ levels plays an important role in the modulation of hypoxia-induced gene expression and dopamine release.
We examined the expression of adenosine deaminase in PC12 cells by RT-PCR, and found that the cells express this enzyme. Since adenosine deaminase catalyses the first step of adenosine degradation, our result suggests that PC12 cells produce adenosine. If adenosine were released from PC12 cells during hypoxia, it seems possible that adenosine, in turn, acts in an autocrine- or paracrine-like fashion to regulate the cellular response to hypoxia via the A2 receptors. There is growing evidence that this might indeed be the case. For example, it has been reported that the A2 receptor in PC12 cells is activated by endogenously released adenosine (Erny, Berezo & Perlman, 1981). In addition, it has been reported that there is a direct linkage between adenosine production and the breakdown of ATP during hypoxia (Winn et al. 1981), since the major source of adenosine is from the breakdown of intracellular ATP (Dubyak & El-Moatassim, 1993). If adenosine is released and mediates feedback regulation of ionic currents in PC12 cells during hypoxia, we would expect to find that the hypoxia-induced inhibition of IK(V) is enhanced in the presence of an adenosine receptor antagonist. We examined this possibility; however, we failed to measure any difference in these experiments (data not shown). The lack of effect of the antagonist might be due to the fact that the concentration of adenosine failed to reach a high enough level to produce any effect. This is because (1) the cells were plated sparsely and any adenosine released may have been diluted to such an extent that the effective concentration was never reached, and (2) the cells were continuously superfused and thus any adenosine released would have been washed away. However, under in vivo conditions, where the cells are contained in a small volume, the situation is very different. A recent study demonstrated that increasing the intracellular concentration of adenosine applied through the patch-clamp pipette in a single neuron selectively inhibits the excitatory postsynaptic potentials in that cell, which is consistent with the hypothesis that adenosine acts as a feedback to regulate the cellular response to various stimuli (Brundege & Dunwiddie, 1996). Further studies are required to confirm the hypothesis that the cellular membrane exicitability of PC12 cells during hypoxia is regulated by endogenous adenosine in a feedback manner.
Acknowledgments
This study was supported by National Institutes of Health grants R37 HL 33831 (D. E. M.) and HL 59945 (D. E. M.).
References
- Brundege JM, Dunwiddie TV. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. Journal of Neuroscience. 1996;16:5603–5612. doi: 10.1523/JNEUROSCI.16-18-05603.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bruns RF. Adenosine receptors: roles and pharmacology. Annals of the New York Academy of Sciences. 1990;603:211–226. doi: 10.1111/j.1749-6632.1990.tb37674.x. [DOI] [PubMed] [Google Scholar]
- Buckler KJ, Vaughan-Jones RD. Effects of hypoxia on membrane potential and intracellular calcium in rat neonatal carotid body type I cells. Journal of Physiology. 1994;476:423–428. doi: 10.1113/jphysiol.1994.sp020143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chern Y, Lai HL, Fong JC, Liang Y. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Molecular Pharmacology. 1993;44:950–958. [PubMed] [Google Scholar]
- Conforti L, Millhorn DE. Selective inhibition of a slow-inactivating voltage-dependent K+ channel in rat PC12 cells by hypoxia. Journal of Physiology. 1997;502:293–305. doi: 10.1111/j.1469-7793.1997.293bk.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacological Reviews. 1994;46:449–466. [PubMed] [Google Scholar]
- Doupnik CA, Pun RYK. Cyclic AMP-dependent phosphorylation modifies the gating properties of L-type Ca2+ channels in bovine adrenal chromaffin cells. Pflügers Archiv. 1992;420:61–71. doi: 10.1007/BF00378642. [DOI] [PubMed] [Google Scholar]
- Dubyak GR, El-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. American Journal of Physiology. 1993;265:C577–606. doi: 10.1152/ajpcell.1993.265.3.C577. [DOI] [PubMed] [Google Scholar]
- Erny RE, Berezo MW, Perlman RL. Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine. Journal of Biological Chemistry. 1981;256:1335–1339. [PubMed] [Google Scholar]
- Fredholm BB. Purinoreceptors in the nervous system. Pharmacology and Toxicology. 1995;76:228–239. doi: 10.1111/j.1600-0773.1995.tb00135.x. [DOI] [PubMed] [Google Scholar]
- Fredholm BB, Dunwiddie TV. How does adenosine inhibit transmitter release? Trends in Pharmacological Sciences. 1988;9:130–134. doi: 10.1016/0165-6147(88)90194-0. 10.1016/0165-6147(88)90194-0. [DOI] [PubMed] [Google Scholar]
- Gerber U, Greene RW, Haas HL, Stevens DR. Characterization of inhibition mediated by adenosine in the hippocampus of the rat in vitro. Journal of Physiology. 1989;417:567–578. doi: 10.1113/jphysiol.1989.sp017819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ginty DD, Glowacka D, Defranco C, Wagner JA. Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. Journal of Biological Chemistry. 1991;266:15325–15333. [PubMed] [Google Scholar]
- Glass DB, Lundquist LJ, Katz BM, Walsh DA. Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. Journal of Biological Chemistry. 1989;264:14579–14584. [PubMed] [Google Scholar]
- Gonzalez C, Almaraz L, Obeso A, Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiological Reviews. 1994;74:829–898. doi: 10.1152/physrev.1994.74.4.829. [DOI] [PubMed] [Google Scholar]
- Greene RW, Haas HL. Adenosine actions on CA1 pyramidal neurons in rat hippocampal slices. Journal of Physiology. 1985;366:119–127. doi: 10.1113/jphysiol.1985.sp015788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greene LA, Tischler AS. Establishment of a nor-adrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the USA. 1976;73:2424–2428. doi: 10.1073/pnas.73.7.2424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv. 1981;391:85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
- Hide I, Padgett WL, Jacobson KA, Daly JW. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cell: characterization with radioligand binding and by activation of adenylate cyclase. Molecular Pharmacology. 1992;41:352–359. [PMC free article] [PubMed] [Google Scholar]
- Inoue K, Watano T, Koizumi S, Nakazawa K, Burnstock G. Dual modulation by adenosine of ATP-activated channels through GTP-binding proteins in rat pheochromocytoma PC12 cells. European Journal of Pharmacology. 1994;268:223–229. doi: 10.1016/0922-4106(94)90192-9. [DOI] [PubMed] [Google Scholar]
- Kleppisch T, Nelson MT. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proceedings of the National Academy of Sciences of the USA. 1995;92:12441–12445. doi: 10.1073/pnas.92.26.12441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lopez-Barneo J. Oxygen-sensing by ion channels and the regulation of cellular functions. Trends in Neurosciences. 1996;19:435–440. doi: 10.1016/0166-2236(96)10050-3. [DOI] [PubMed] [Google Scholar]
- Mogul DJ, Adams ME, Fox AP. Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons. Neuron. 1993;10:327–334. doi: 10.1016/0896-6273(93)90322-i. [DOI] [PubMed] [Google Scholar]
- Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annual Review of Pharmacology and Toxicology. 1995;35:581–606. doi: 10.1146/annurev.pa.35.040195.003053. [DOI] [PubMed] [Google Scholar]
- Otsuguro K, Ohta T, Ito S, Nakazato Y. Modulation of calcium current by ATP in guinea-pig adrenal chromaffin cells. Pflügers Archiv. 1996;431:402–407. doi: 10.1007/BF02207278. [DOI] [PubMed] [Google Scholar]
- Palmer TM, Stiles GL. The new biology of adenosine receptors. Advances in Enzymology and Related Areas of Molecular Biology. 1994;69:83–120. doi: 10.1002/9780470123157.ch3. [DOI] [PubMed] [Google Scholar]
- Poucher SM, Keddie JR, Singh P, Stoggall SM, Caulkett PWR, Jones G, Collis MG. The in vitro pharmacology of ZM241385, a potent, non-xanthine, A2a selective adenosine receptor antagonist. British Journal of Pharmacology. 1995;115:1096–1102. doi: 10.1111/j.1476-5381.1995.tb15923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raymond R, Millhorn DE. Regulation of tyrosine hydroxylase gene expression during hypoxia: role of Ca2+ and PKC. Kidney International. 1997;51:536–541. doi: 10.1038/ki.1997.74. [DOI] [PubMed] [Google Scholar]
- Schackow TE, Ten Eick RE. Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by β-adrenoreceptor stimulation. Journal of Physiology. 1994;474:131–270. doi: 10.1113/jphysiol.1994.sp020008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scholz KP, Miller RJ. Analysis of adenosine action on Ca2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. Journal of Physiology. 1991;435:373–393. doi: 10.1113/jphysiol.1991.sp018515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smellie FW, Davis CW, Daly JW, Wells JN. Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sciences. 1979;24:2475–2481. doi: 10.1016/0024-3205(79)90458-2. [DOI] [PubMed] [Google Scholar]
- Sperelakis N, Xiong Z, Haddad G, Masuda H. Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation. Molecular and Cellular Biochemistry. 1994;140:103–117. doi: 10.1007/BF00926749. [DOI] [PubMed] [Google Scholar]
- Van der Ploeg I, Ahlberg S, Parkinson FE, Olsson RA, Fredholm BB. Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Archives of Pharmacology. 1996;353:250–260. doi: 10.1007/BF00168626. [DOI] [PubMed] [Google Scholar]
- Wickman K, Claphan DE. Ion channel regulation by G protein. Physiological Reviews. 1995;75:865–885. doi: 10.1152/physrev.1995.75.4.865. [DOI] [PubMed] [Google Scholar]
- Williams M, Abreu M, Jarvis MF, Noronha-Blob L. Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivity. Journal of Neurochemistry. 1987;48:498–502. doi: 10.1111/j.1471-4159.1987.tb04120.x. [DOI] [PubMed] [Google Scholar]
- Winn HR, Rubio R, Berne RM. Brain adenosine concentration during hypoxia in rats. American Journal of Physiology. 1981;241:H235–242. doi: 10.1152/ajpheart.1981.241.2.H235. [DOI] [PubMed] [Google Scholar]
- Zhu WH, Conforti L, Czyzyk-Krzeska MF, Millhorn DE. Membrane depolarization in PC12 cells during hypoxia is regulated by an O2 sensitive K+ current. American Journal of Physiology. 1996;271:C658–665. doi: 10.1152/ajpcell.1996.271.2.C658. [DOI] [PubMed] [Google Scholar]
- Zhu WH, Conforti L, Millhorn DE. Expression of dopamine D2 receptor in PC12 cells and regulation of membrane conductances by dopamine. FASEB Journal. 1997;273:C1143–1150. doi: 10.1152/ajpcell.1997.273.4.C1143. [DOI] [PubMed] [Google Scholar]
